Dive Brief: Moderna on Wednesday said it has begun a trial testing a new version of its COVID-19 vaccine that’s tailored to the omicron variant, …
Sanofi and GSK expected to have definitive results for their long-delayed coronavirus vaccine by now, having redesigned their shot after an initial formulation disappointed late …
Three doses of Pfizer and BioNTech’s COVID-19 vaccine may protect against the new omicron variant similarly well as two doses did against the original coronavirus …
